Advertisement

Topics

Eisai targets dementia drug discovery with US research facility

12:54 EDT 13 Jun 2018 | BioPharma-Reporter

Eisai says it is creating a research facility for âgenetics-guided dementia discoveryâ in the US and joining a Japanese industry-academia-government collaboration aimed at developing nucleic acid-based drugs.

Original Article: Eisai targets dementia drug discovery with US research facility

NEXT ARTICLE

More From BioPortfolio on "Eisai targets dementia drug discovery with US research facility"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Alzheimer's Disease
Of all the types of Dementia, Alzheimer's disease is the most common, affecting around 465,000 people in the UK. Neurons in the brain die, becuase  'plaques' and 'tangles' (mis-folded proteins) form in the brain. People with Al...

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...